MedTrace Logo

Preoperative Pain Control in Gastric Bypass Surgery Patients

NCT01801189 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2022-07-14

Study results available
· View outcomes & findings →

Summary

Randomized clinical trial to evaluate whether a single pre-operative dose of Pregabalin will alleviate post-operative pain and decrease post-operative analgesic requirements in morbidly obese patients undergoing laparoscopic gastric bypass surgery.

Conditions

  • Post-operative Pain

Interventions

DRUG

Pregabalin

One 300 mg oral dose of Pregabalin given before surgery.

DRUG

Placebo (for Pregabalin)

One oral dose of placebo given before surgery.

Sponsors & Collaborators

  • Legacy Health System

    lead OTHER

Principal Investigators

  • Valerie Halpin, MD · Legacy Health System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01801189 on ClinicalTrials.gov